CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults

Journal of Applied Physiology

Volumn 95, Issue 3, 2003, Pages 1297-1300

  Givens, Raymond C ^a,b   Lin, Yvonne S ^c   Dowling, Amy L S ^c   Thummel, Kenneth E ^c   Lamba, Jatinder K ^d   Schuetz, Erin G ^d   Stewart, Paul W ^a   Watkins, Paul B ^a,e  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Cytochrome P 450 3A5; Kidney; Single nucleotide polymorphism; Sodium sensitivity

Indexed keywords

CREATININE; CYTOCHROME P450 3A5;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CATALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; ENZYME ACTIVITY; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; KIDNEY MICROSOME; MEAN ARTERIAL PRESSURE; NEGRO; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

EID: 0041421011     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00322.2003     Document Type: Article

References (17)

1. Clore J, Schoolwerth A, and Watlington CO. When is cortisol a mineralocorticoid? Kidney Int 42: 1297-1308, 1992.
2. Cornoni-Huntley J, LaCroix AZ, and Havlik RJ. Race and sex differentials in the impact of hypertension in the United States: the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 149: 780-788, 1989.
3. + transport stimulation in A6 cells. Am J Physiol Renal Fluid Electrolyte Physiol 255: F736-F748, 1988.
4. Ghosh SS, Basu AK, Ghosh S, Hagley R, Kramer L, Schuetz J, Grogan WM, Guzelian P, and Watlington CO. Renal and hepatic family 3A cytochromes P450 (CYP3A) in spontaneously hypertensive rats. Biochem Pharmacol 50: 49-54, 1995.
5. Haehner BD, Gorski JC, Vandenbranden M, Wrighton SA, Janardan SK, Watkins PB, and Hall SD. Bimodal distribution of renal cytochrome P450 3A activity in humans. Mol Pharmacol 50: 52-59, 1996.
6. Hustert E, Haberl M, Burk O, Wolbold R, He YQ, Klein K, Nuessler AC, Neuhaus P, Klattig J, Eiselt R, Koch I, Zibat A, Brockmöller J, Halpert JR, Zanger UM, and Wojnowski L. The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics 11: 773-779, 2001.
7. Joint National Committee. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157: 2413-2446, 1997.
8. Koch I, Weil R, Wolbold R, Brockmöller J, Hustert E, Burk O, Nuessler AC, Neuhaus P, Eichelbaum M, Zanger UM, and Wojnowski L. Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metab Dispos 30: 1108-1114, 2002.
9. Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS, and Schuetz E. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27: 383-391, 2001.
10. Lin YS, Dowling ALS, Quigley SD, Farin FM, Zhang J, Lamba J, Schuetz EG, and Thummel KE. Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. Mol Pharmacol 62: 162-172, 2002.
11. Matsuzaki K, Arai T, Miyazaki T, and Yasuda K. Formation of 6 beta-OH-deoxycorticosterone from deoxycorticosterone by A6 cells. Steroids 60: 457-462, 1995.
12. McCarron P, Okasha M, McEwen J, and Davey Smith G. Blood pressure in early life and cardiovascular disease mortality. Arch Intern Med 162: 610-611, 2002.
13. Morris DJ, Latif SA, Rokaw MD, Watlington CO, and Johnson JP. A second enzyme protecting mineralocorticoid receptors from glucocorticoid occupancy. Am J Physiol Cell Physiol 274: C1245-C1252, 1998.
14. Murray GI, McFadyen MC, Mitchell RT, Cheung YL, Kerr AC, and Melvin WT. Cytochrome P450 CYP3A in human renal cell cancer. Br J Cancer 79: 1836-1842, 1999.
15. Murray GI, Pritchard S, Melvin WT, and Burke D. Cytochrome P450 CYP3A5 in the human anterior pituitary gland. FEBS Lett 364: 79-82, 1995.
16. Watlington CO, Kramer LB, Schuetz EG, Zilai J, Grogan WM, Guzelian P, Gizek F, and Schoolwerth AC. Corticosterone 6 beta-hydroxylation correlates with blood pressure in spontaneously hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 262: F927-F931, 1992.
17. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 27: 481-490, 1996.